KPJ Healthcare Berhad (“KPJ Healthcare” or “the Group”) achieved a historic milestone for the quarter ended 30 September 2024 (“Q3 FY2024”), recording its highest-ever quarterly revenue of RM1,032.8 million. The Group surpassed RM1 billion in quarterly revenue for the first time, driven by increased patient volumes and expanded bed capacity across its network.
PBT for the quarter stood at RM139.6 million, a 2% increase compared to the same period last year. The Group’s Earnings Before Interest, Taxes, Depreciation and Amortisation (“EBITDA”) was RM253.7 million. Excluding a one-off gain of RM34.8 million from the disposal of Indonesian operations in Q3 FY2023, EBITDA grew 14%, reflecting strong operational performance.
For the nine months ended 30 September 2024, KPJ Healthcare reported revenue of RM2,871.4 million, a 15% increase from RM2,507.2 million in the corresponding period last year. PBT for the period increased by 19% to RM349.7 million, while EBITDA increased by 7% to RM687.3 million, reflecting sustained operational performance.
Following these strong results, KPJ Healthcare has declared a fourth interim dividend for FY2024 of 1.15 sen per share, totalling RM50.2 million. This dividend will be disbursed to KPJ Healthcare shareholders on 27 December 2024.
Chin Keat Chyuan, President and Managing Director of KPJ Healthcare, commented, “Achieving RM1 billion in quarterly revenue for the first time is a testament to our ability to deliver high-quality, patient-centred healthcare while continually improving our operational performance. This milestone reflects the trust placed in us by our patients and stakeholders. With enhanced service offerings and increased bed capacity, we are driving patient satisfaction and achieving stronger results. We remain focused on delivering even greater value as we expand our services to meet the nation’s growing healthcare needs."
The Group sustained strong operational momentum in Q3 FY2024, achieving a BOR of 72%. Inpatient admissions rose by 6% to 103,228, while outpatient visits increased to 784,437, reflecting KPJ’s continued commitment to providing accessible and effective healthcare services.
Enhanced hospital operations resulted in operating cash flows of RM554.3 million for the period ended 30 September 2024, a 5% increase (RM26.9 million) from RM527.4 million in FY2023. Meanwhile, net cash used in investing activities decreased by RM54.1 million to RM109.6 million during the same period.
Net cash used in financing activities stood at RM360.8 million, an increase of RM165.6 million compared to FY2023, due to higher net repayments of borrowings during the period.
In addition to its financial achievements, KPJ continued to advance its sustainability initiatives. Damansara Specialist Hospital 2 (“DSH2”) became the Group's first hospital to achieve Green Building Index (“GBI”) certification, setting a benchmark for eco-friendly healthcare. KPJ Rawang’s rooftop solar photovoltaic system is expected to reduce carbon emissions equivalent to saving 3,000 trees annually, aligning with Malaysia’s broader environmental goals.
The Group is focused on asset optimisation, bed expansion and talent acquisition to strengthen its operational capabilities. While addressing challenges such as cost pressures and a competitive talent market, KPJ Healthcare is committed to prudent financial management and delivering value to all stakeholders. The Group remains confident on its prospects for the financial year ending 31 December 2024.
This content is provided by KPJ Healthcare Berhad.
The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.
Interested in having your announcements on Malaysiakini? Contact the announcements team at [email protected] or WhatsApp on +60 17-323 0707 for urgent matters.
